AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,142,287 | +12.4% | 46,153 | +28.6% | 0.00% | 0.0% |
| Q2 2023 | $1,016,461 | +78.5% | 35,892 | +42.1% | 0.00% | – |
| Q1 2023 | $569,590 | -1.3% | 25,259 | +23.0% | 0.00% | – |
| Q4 2022 | $576,847 | +137.4% | 20,543 | +139.1% | 0.00% | – |
| Q3 2022 | $243,000 | -83.9% | 8,592 | -81.5% | 0.00% | -100.0% |
| Q3 2019 | $1,506,000 | -74.7% | 46,472 | -61.1% | 0.00% | -66.7% |
| Q2 2019 | $5,962,000 | -20.7% | 119,526 | +7.2% | 0.01% | -25.0% |
| Q1 2019 | $7,521,000 | +67.5% | 111,526 | +14.5% | 0.01% | +60.0% |
| Q4 2018 | $4,490,000 | -17.0% | 97,366 | +16.9% | 0.01% | -16.7% |
| Q4 2015 | $5,409,000 | -56.0% | 83,316 | -52.2% | 0.01% | -60.0% |
| Q3 2015 | $12,303,000 | -36.5% | 174,286 | -0.0% | 0.02% | -31.8% |
| Q2 2015 | $19,371,000 | +1909.4% | 174,296 | +1605.1% | 0.02% | +2100.0% |
| Q1 2015 | $964,000 | -16.4% | 10,222 | -0.7% | 0.00% | 0.0% |
| Q4 2014 | $1,153,000 | +100.9% | 10,293 | +10.1% | 0.00% | 0.0% |
| Q3 2014 | $574,000 | – | 9,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |